title: Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours.
abstract: Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment of primary and secondary lung tumours is appraised, and key ongoing trials are identified.
authors.affiliation: CyberKnife Centre, The Harley Street Clinic, London, UK. christy.goldsmith@hcahealthcare.co.uk
authors.forename: Christy
authors.initials: C
authors.lastname: Goldsmith
authors.forename: Andrew
authors.initials: A
authors.lastname: Gaya
mesh_terms: D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D011829:Radiation Dosage; D016634:Radiosurgery / Q000379:methods*